Mineralys submits NDA for lorundrostat, raises $578M, targets Dec 2026 approval
Filed March 12, 2026 · Period ending December 31, 2025 · Compared to 10-K Feb 12, 2025 · ~1 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade MLYS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 5, 2026 2:10 AM